SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001829126-23-007698
Filing Date
2023-11-28
Accepted
2023-11-28 16:47:46
Documents
1
Period of Report
2023-12-27

Document Format Files

Seq Description Document Type Size
1 DEF 14A titanpharma_def14a.htm DEF 14A 136264
  Complete submission text file 0001829126-23-007698.txt   137322
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

IRS No.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-13341 | Film No.: 231447197
SIC: 2836 Biological Products, (No Diagnostic Substances)